Published in J Neurochem on November 08, 2005
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Calcitonin gene-related peptide (CGRP) and migraine. Headache (2006) 1.25
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One (2011) 1.13
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med (2011) 1.13
Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study. J Neuroinflammation (2011) 1.10
Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain (2010) 1.09
Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache (2009) 1.04
Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol (2014) 1.00
Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine. Headache (2008) 0.99
Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology (2010) 0.99
Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience (2007) 0.97
Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons. Headache (2007) 0.96
Tumor necrosis factor-α increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner. Neuroscience (2011) 0.93
TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS One (2013) 0.93
Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment. Headache (2012) 0.92
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. J Neurosci (2013) 0.90
CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways. J Neurochem (2009) 0.89
Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neurosci Lett (2010) 0.88
Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect (2010) 0.85
Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. J Headache Pain (2015) 0.83
The mechanism of functional up-regulation of P2X3 receptors of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine type 1 (FHM-1). PLoS One (2013) 0.82
Neurogenic inflammation: a study of rat trigeminal ganglion. J Headache Pain (2010) 0.82
Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart. Am J Physiol Heart Circ Physiol (2013) 0.82
PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells. Br J Pharmacol (2014) 0.82
TNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion. Sci Rep (2016) 0.81
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache (2014) 0.80
DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons. Headache (2010) 0.79
Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World J Gastroenterol (2015) 0.79
Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients. J Orthop Surg Res (2016) 0.78
Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats. Sci Rep (2015) 0.78
Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol (2007) 0.78
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells. J Headache Pain (2016) 0.76
CGRP as a neuropeptide in migraine: lessons from mice. Br J Clin Pharmacol (2015) 0.75
Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons. Arch Oral Biol (2016) 0.75
Expression of calcitonin gene-related peptide in the infrapatellar fat pad in knee osteoarthritis patients. J Orthop Surg Res (2017) 0.75
Slick (Kcnt2) Sodium-Activated Potassium Channels Limit Peptidergic Nociceptor Excitability and Hyperalgesia. J Exp Neurosci (2017) 0.75
Electroacupuncture at Fengchi (GB20) inhibits calcitonin gene-related peptide expression in the trigeminovascular system of a rat model of migraine. Neural Regen Res (2017) 0.75
Increase and regulation of synovial calcitonin gene-related peptide expression in patients with painful knee osteoarthritis. J Pain Res (2017) 0.75
Migraine--current understanding and treatment. N Engl J Med (2002) 9.80
Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem (1995) 9.56
TNF-R1 signaling: a beautiful pathway. Science (2002) 7.98
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell (1995) 5.08
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med (1996) 2.74
Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev (2002) 2.69
Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci (1995) 2.51
Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem (2001) 2.50
Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci (1995) 2.28
Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov (2003) 2.18
Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron (1994) 2.09
"Inflammatory" cytokines: neuromodulators in normal brain? J Neurochem (2000) 1.80
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache (2004) 1.76
Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain (1994) 1.72
RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol (1996) 1.63
Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain (2001) 1.61
Plasma cytokine levels in migraineurs and controls. Headache (2005) 1.48
Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem (2002) 1.41
TNFalpha contributes to the death of NGF-dependent neurons during development. Nat Neurosci (2001) 1.33
Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J Neurosci (2003) 1.33
Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain (2001) 1.29
Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci (1999) 1.27
Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci (2003) 1.24
The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J (2001) 1.23
TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacology (2002) 1.22
Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain (1995) 1.19
Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J Neurosci (2004) 1.10
Neurogenic inflammation in the context of migraine. Microsc Res Tech (2001) 1.09
Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci (2003) 1.07
Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology (2004) 1.05
Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol (Noisy-le-grand) (2001) 1.05
Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J Biol Chem (1986) 1.04
Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst (1998) 1.02
Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem Res (2001) 1.02
Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J Leukoc Biol (1998) 1.02
MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci (2002) 1.01
Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia (2001) 1.01
Neurogenic model of migraine. Cephalalgia (1995) 0.98
Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J Biol Chem (1997) 0.98
Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors. J Biol Chem (1993) 0.95
Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br J Pharmacol (1994) 0.95
Stimulation of MAPK cascades by insulin and osmotic shock: lack of an involvement of p38 mitogen-activated protein kinase in glucose transport in 3T3-L1 adipocytes. Diabetes (2000) 0.94
Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. Mol Endocrinol (2000) 0.92
Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem (2004) 0.91
The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol (2003) 0.90
Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res (2004) 0.90
Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases. Curr Opin Biotechnol (2004) 0.88
Decreased sTNF-RI in migraine patients? Cephalalgia (2003) 0.88
Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis. J Orofac Pain (1995) 0.87
Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs (2001) 0.86
Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion. Brain Res Mol Brain Res (2003) 0.85
Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol Endocrinol (1998) 0.84
A polymorphism in the interleukin-1alpha gene influences the clinical features of migraine. Headache (2002) 0.84
Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem (2004) 0.82
Relation between intra-articular temperature of the arthritic temporomandibular joint and presence of calcitonin gene-related peptide in the joint fluid. A clinical study. Acta Odontol Scand (1993) 0.81
Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg (1995) 0.80
Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Cephalalgia (1990) 0.79
In vivo administration of propranolol decreases exaggerated amounts of serum TNF-alpha in patients with migraine without aura. Possible mechanism of action. Acta Neurol (Napoli) (1993) 0.78
New insights into peripheral chemical mediators of temporomandibular pain and inflammation. J Orofac Pain (2001) 0.78
Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache (2007) 2.36
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci (2007) 1.50
Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke (2010) 1.48
Amylin acts in the central nervous system to increase sympathetic nerve activity. Endocrinology (2013) 1.47
Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci (2009) 1.30
Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem (2004) 1.25
Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci (2003) 1.24
Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res (2008) 1.20
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation. Expert Rev Mol Med (2011) 1.13
Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci (2006) 1.10
Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol (2009) 1.05
Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain (2011) 1.04
Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling. Headache (2009) 1.04
Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology (2009) 1.04
Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice. J Pain (2009) 1.02
Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache (2006) 1.01
Calcitonin gene-related peptide: an update on the biology. Curr Opin Neurol (2009) 1.01
Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache (2009) 0.98
Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci (2012) 0.98
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice. J Clin Invest (2011) 0.95
Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension (2010) 0.93
Dominant negative dimerization of a mutant homeodomain protein in Axenfeld-Rieger syndrome. Mol Cell Biol (2003) 0.93
Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology (2005) 0.92
Light aversion in mice depends on nonimage-forming irradiance detection. Behav Neurosci (2010) 0.92
CGRP and migraine: could PACAP play a role too? Neuropeptides (2013) 0.90
Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndrome. Birth Defects Res A Clin Mol Teratol (2004) 0.90
Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res (2004) 0.90
New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol Ther (2002) 0.89
An unusual class of PITX2 mutations in Axenfeld-Rieger syndrome. Birth Defects Res A Clin Mol Teratol (2006) 0.88
Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis. Neurosci Lett (2010) 0.88
Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice. Diabetes (2011) 0.86
Calcium receptor-induced serotonin secretion by parafollicular cells: role of phosphatidylinositol 3-kinase-dependent signal transduction pathways. J Neurosci (2003) 0.85
Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Mol Pain (2010) 0.85
Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res (2010) 0.85
Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A. J Biol Chem (2004) 0.84
Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. IDrugs (2007) 0.84
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache. Otolaryngol Head Neck Surg (2006) 0.83
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc (2005) 0.82
NCS-1 inhibits insulin-stimulated GLUT4 translocation in 3T3L1 adipocytes through a phosphatidylinositol 4-kinase-dependent pathway. J Biol Chem (2002) 0.82
Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem (2004) 0.82
Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons. J Biol Chem (2007) 0.80
Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache (2014) 0.80
DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons. Headache (2010) 0.79
Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses. J Orofac Pain (2012) 0.79
Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia. Cephalalgia (2011) 0.79
Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity. J Biol Chem (2013) 0.79
Ramping it up: RAMP1 and the implications for migraine. Pharmacogenomics (2007) 0.78
Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen. Headache (2011) 0.78
Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol (2007) 0.78
Prolonged Jaw Opening Promotes Nociception and Enhanced Cytokine Expression. J Oral Facial Pain Headache (2016) 0.76
CGRP receptor antagonists: A new frontier of anti-migraine medications. Drug Discov Today Ther Strateg (2006) 0.76
Inclusion of cocoa as a dietary supplement represses expression of inflammatory proteins in spinal trigeminal nucleus in response to chronic trigeminal nerve stimulation. Mol Nutr Food Res (2013) 0.75
Central Role of Protein Kinase A in Promoting Trigeminal Nociception in an In Vivo Model of Temporomandibular Disorders. J Oral Facial Pain Headache (2017) 0.75
Homeobox protein, Hmx3, in postnatally developing rat submandibular glands. J Histochem Cytochem (2003) 0.75
CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice. J Clin Invest (2015) 0.75
Duplicate publication. Otolaryngol Head Neck Surg (2006) 0.75